FI66120C - Foerfarande foer stabilisering av 4-metyl-5-(2'-kloretyl)-tiazol - Google Patents

Foerfarande foer stabilisering av 4-metyl-5-(2'-kloretyl)-tiazol Download PDF

Info

Publication number
FI66120C
FI66120C FI791324A FI791324A FI66120C FI 66120 C FI66120 C FI 66120C FI 791324 A FI791324 A FI 791324A FI 791324 A FI791324 A FI 791324A FI 66120 C FI66120 C FI 66120C
Authority
FI
Finland
Prior art keywords
mixture
cmt
base
carrier
fatty acids
Prior art date
Application number
FI791324A
Other languages
English (en)
Finnish (fi)
Other versions
FI791324A (fi
FI66120B (fi
Inventor
Horst Felsch
Gerhard Hantich
Original Assignee
Pharmaceutical Licences Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaceutical Licences Co filed Critical Pharmaceutical Licences Co
Publication of FI791324A publication Critical patent/FI791324A/fi
Application granted granted Critical
Publication of FI66120B publication Critical patent/FI66120B/fi
Publication of FI66120C publication Critical patent/FI66120C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Lubricants (AREA)
FI791324A 1978-04-25 1979-04-24 Foerfarande foer stabilisering av 4-metyl-5-(2'-kloretyl)-tiazol FI66120C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT296178A AT358530B (de) 1978-04-25 1978-04-25 Stabilisierungsverfahren
AT296178 1978-04-25

Publications (3)

Publication Number Publication Date
FI791324A FI791324A (fi) 1979-10-26
FI66120B FI66120B (fi) 1984-05-31
FI66120C true FI66120C (fi) 1984-09-10

Family

ID=3543124

Family Applications (1)

Application Number Title Priority Date Filing Date
FI791324A FI66120C (fi) 1978-04-25 1979-04-24 Foerfarande foer stabilisering av 4-metyl-5-(2'-kloretyl)-tiazol

Country Status (23)

Country Link
US (1) US4247702A (no)
EP (1) EP0005121B1 (no)
JP (1) JPS54147914A (no)
AT (1) AT358530B (no)
AU (1) AU523518B2 (no)
CA (1) CA1113941A (no)
CS (1) CS208779B2 (no)
DD (1) DD142962A5 (no)
DE (2) DE2963835D1 (no)
DK (1) DK155978C (no)
ES (1) ES480590A1 (no)
FI (1) FI66120C (no)
GR (1) GR66987B (no)
HU (1) HU179741B (no)
IE (1) IE48778B1 (no)
IL (1) IL57292A (no)
NO (1) NO150317C (no)
NZ (1) NZ190240A (no)
PT (1) PT69532A (no)
SU (1) SU959626A3 (no)
UA (1) UA5545A1 (no)
YU (1) YU42302B (no)
ZA (1) ZA791661B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58159425A (ja) * 1982-03-18 1983-09-21 Fujisawa Pharmaceut Co Ltd ゲル基剤
SE9303281D0 (sv) * 1993-10-07 1993-10-07 Astra Ab New formulation
DE60010913T2 (de) * 1999-10-15 2005-06-09 Sucampo Ag Bizyklische Verbindungen, Zusammenstellung und Verfahren zu ihrer Stabilisierung
US9884024B2 (en) * 2005-12-27 2018-02-06 Hemant N Joshi Physically dispersed, molecularly dissolved and/or chemically bound drug(s) in an empty, hard capsule shell composition
JP2013032289A (ja) * 2009-10-28 2013-02-14 Daiichi Sankyo Co Ltd ワックス安定製剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2844512A (en) * 1954-11-05 1958-07-22 Upjohn Co Fumagillin enveloped in fatty or waxy substance and enclosed in ultraviolet opaque container
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
FR1416304A (fr) * 1961-10-10 1965-11-05 Smith Kline French Lab Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
FR1536904A (fr) * 1962-12-19 1968-09-02 Smith Kline French Lab Procédé de préparation de pilules pharmaceutiques à libération progressive de leur principe actif
SE319577B (no) * 1966-03-08 1970-01-19 Astra Ab
JPS4971127A (no) * 1972-11-18 1974-07-10
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.
NL7510104A (nl) * 1975-08-27 1977-03-01 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.
DE2631281A1 (de) * 1976-07-12 1978-01-19 Kali Chemie Pharma Gmbh Verfahren zur erhoehung der loeslichkeit von schwerloeslichen arzneistoffen zum zwecke deren applikation in gelatinekapseln
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof

Also Published As

Publication number Publication date
DE2963835D1 (en) 1982-11-18
ZA791661B (en) 1980-04-30
IE790836L (en) 1979-10-25
PT69532A (de) 1979-05-01
JPS6337791B2 (no) 1988-07-27
US4247702A (en) 1981-01-27
CA1113941A (en) 1981-12-08
DD142962A5 (de) 1980-07-23
NZ190240A (en) 1980-10-24
AU4637379A (en) 1979-11-01
GR66987B (no) 1981-05-15
DE2916573C2 (de) 1982-09-02
NO791339L (no) 1979-10-26
DK155978C (da) 1989-10-30
YU91079A (en) 1984-10-31
JPS54147914A (en) 1979-11-19
HU179741B (en) 1982-12-28
EP0005121B1 (de) 1982-10-13
DK155978B (da) 1989-06-12
AU523518B2 (en) 1982-07-29
ES480590A1 (es) 1980-08-16
CS208779B2 (en) 1981-09-15
NO150317C (no) 1984-09-26
FI791324A (fi) 1979-10-26
EP0005121A3 (en) 1979-11-28
NO150317B (no) 1984-06-18
DE2916573A1 (de) 1979-10-31
UA5545A1 (uk) 1994-12-28
DK167879A (da) 1979-10-26
SU959626A3 (ru) 1982-09-15
IE48778B1 (en) 1985-05-15
ATA296178A (de) 1980-02-15
IL57292A (en) 1982-11-30
FI66120B (fi) 1984-05-31
AT358530B (de) 1980-09-10
YU42302B (en) 1988-08-31
EP0005121A2 (de) 1979-10-31

Similar Documents

Publication Publication Date Title
EP1834639B1 (en) Remedial agent for fat toxicity
CA2150576C (fr) Compositions injectables a base de derives des taxanes
CA2102777C (fr) Nouvelles compositions a base de derives de la classe des taxanes
FR2553662A1 (fr) Composition d'acides gras combines, pour reduire les taux de triglycerides et de cholesterol du sang
FI66120C (fi) Foerfarande foer stabilisering av 4-metyl-5-(2'-kloretyl)-tiazol
FR2541287A1 (fr) Preparation stable administrable par voie orale de macrolides antibiotiques et procede pour les stabiliser
FR2524314A1 (fr) Medicament a action salidiuretique, contenant des dihydropyridines
JPH0761954B2 (ja) コレステロール低下または上昇抑制剤
JPH01153629A (ja) 制癌剤
JPH04288016A (ja) 活性型ビタミンｄ３類軟カプセル剤の製造方法
CA2325887A1 (fr) Procede d'obtention d'une huile enrichie en acides gras hydroxyoctadecadienoiques (hode) ou de ses esters, a partir d'un melange huileux contenant de l'acide linoleique, ou ses esters
JPS58213716A (ja) 制癌剤
WO1984002523A1 (fr) Enamides acyles et compositions pharmaceutiques les contenant
WO2003097033A2 (fr) Nouvelle compositions neutraceutiques et pharmaceutiques et leurs utilisations
FR2517542A1 (fr) Medicament pour l'amelioration du metabolisme lipidique
EP1596845A1 (fr) Utilisation therapeutique de glycerols acyles et de leurs analogues azotes et sulfures
WO1995021624A1 (fr) Preparation sous forme de solution a base d'une forte concentration d'aureobasidine
BE738239A (no)
CH685700A5 (fr) Esters nitriques de 1,2-benzo-isothiazolyl-3(2H)one-1,1-dioxyde, procédé de préparation de ces esters et médicaments contenant ces esters.
JPS58210010A (ja) 抗腫瘍剤
BE894696A (fr) Nouveaux medicaments a base de 9,10-dihydro-ergonine pour le traitement de l'arteriosclerose
JPH05294830A (ja) 直腸投与用のトリアゾール誘導体含有薬剤組成物
BE825194A (fr) Hydrazide de n-benzene-sulfonyl-beta-alanine comme agent immunosupressif sur et actif

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: AB ASTRA